<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
Amendment No. 1
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): October 23, 1995 (October
13, 1995)
CORAM HEALTHCARE CORPORATION
(Exact name of Registrant as specified in its charter)
Delaware 1-11343 33-0615337
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
1125 Seventeenth Street, 15th Floor, Denver, Colorado 80202
(Address of principal executive offices) (Zip Code)
(303) 292-4973
(Registrant's telephone number, including area code)
Not applicable
(Former name or address, if changed since last report)
Page 1 of 3 Pages
<PAGE> 2
ITEM 5. OTHER EVENTS.
On October 13, 1995, the Registrant entered into the Fourth Amendment
and Limited Waiver to Credit Agreement and First Amendment to Security
Documents, attached hereto as Exhibit A, which is incorporated herein in its
entirety by this reference. On October 16, 1995, the Registrant announced that
it had concluded a major debt restructuring, announced that it had named Donald
J. Amaral as is President and Chief Executive Officer, and issued the press
release attached hereto as Exhibit B, which is incorporated herein in its
entirety by this reference.
As part of the restructuring of the terms of the Company's Senior
Credit Facility with Chemical Bank, as agent, the maturity dates were shortened
from April 6, 2000 to March 31, 1997, and the unused portion of the existing
revolving debt commitments of approximately $64.2 million were terminated. The
warrants received by the lenders are for 2,569,342 shares of common stock of
the Company or, at the option of the lenders, 6% of the shares of Coram Inc., a
wholly-owned subsidiary of the company and the immediate parent of the
Company's operating subsidiaries, exercisable at a nominal price over five
years. The fair value of the warrants, estimated to be $8 million, will be
accounted for as interest expense over the term of the debt.
ITEM 7. EXHIBITS.
A. Fourth Amendment and Limited Waiver to Credit Agreement and
First Amendment to Security Documents dated as of October 13, 1995, together
with selected exhibits thereto, by and among the Registrant, Coram Inc., each
Subsidiary Guarantor (as defined therein), the Financial Institutions Party
thereto (as defined therein) and Chemical Bank as Agent.
B. Press Release Issued by the Registrant on October 16, 1995.
Page 2 of 3 Pages
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
Date: April 3, 1996 CORAM HEALTHCARE CORPORATION
(registrant)
By: /s/ Richard M. Smith
---------------------------------
Richard M. Smith
Chief Financial Officer
Page 3 of 3 Pages
<PAGE> 4
EXHIBIT INDEX
<TABLE>
<CAPTION>
EXHIBIT
NUMBER EXHIBIT DESCRIPTION PAGE
- ------- ------------------- ----
<S> <C> <C>
A. Fourth Amendment and Limited Waiver to Credit Agreement
and First Amendment to Security Documents dated as of October
13, 1995, together with selected exhibits thereto, by and
among the Registrant, Coram Inc., each Subsidiary Guarantor
(as defined therein), the Financial Institutions Party
thereto (as defined therein) and Chemical Bank as Agent. *
B. Press Release Issued by the Registrant on October 16,
1995. *
</TABLE>
- -------------------
* Filed in original filing.
